Dankook University Hospital

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation2 trials
• Alopecia areata1 trial
• Coronary artery disease1 trial
• Depression1 trial
• Familial hypercholesterolaemia1 trial
• High blood pressure1 trial

Phase

• Phase 32 trials
• Phase 42 trials

Status

• Completed4 trials
• Not yet recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Celltrion Pharm, Inc.1 trial
• Daiichi Sankyo1 trial
• Duk-Woo Park, MD1 trial
• Eli Lilly and Company1 trial
• Seoul National University Hospital1 trial
• and 1 more

Running trials

• Not yet recruiting

  Functional And STructural Assesment of the Heart by Artificial Intelligence-enabled Electrocardiogram for the Management of Atrial Fibrillation

  NCT07486739· Seoul National University Hospital· Source

  Contact: Dong-Min Kim

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting

Closed trials

• Completed

  Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment

  NCT06664138· Phase 4· Yeongseok Yun· Source

• Completed

  A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation

  NCT05804747· Daiichi Sankyo· Source

• Completed

  Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

  NCT07564726· Phase 3· Celltrion Pharm, Inc.· Source

• Recruiting

  Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

  NCT04416581· Phase 4· Duk-Woo Park, MD· Source

  Contact: Jeong-youn Bae, RN

• Completed

  A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

  NCT03899259· Phase 3· Eli Lilly and Company· Source